RxDoctor Payments DataLook up a doctor →

Sripal Bangalore

Interventional Cardiology · New York, NYNPI 1902066871

Payments from drug & device makers

$799,257in general payments, 2019–2025

Across 592 payments — averaging $1350.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Mylan Inc.$195K
  • Recor Medical Inc$111K
  • Imperative Care, Inc$109K
  • Abbott$82K
  • Penumbra, Inc.$66K
  • Biotronik Inc.$63K
  • plus $174K from 20 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$799,257 in reported general payments places this provider in the 90th percentile of 382 interventional cardiology providers in New York.

See all interventional cardiology providers in New York

Medicare billing

Part B allowed, 2024
$13,533
Medicare patients
13
Services billed
65

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other interventional cardiology in New York

See the full list for New York

Where these figures come from

Is this you, or does something look wrong? →